Robert Hershberg, Director at Adaptive Biotechnologies Corp (ADPT), sold 3,777 shares at $47.60 ($180K) on 2020-11-16, disclosed to the SEC on 2020-11-18.
Open-market sale of $180k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.60 | 1,777 | $85K | 47.0% |
| 2 | $47.60 | 1,777 | $85K | 47.0% |
| 3 | $48.41 | 223 | $11K | 6.0% |
| Total | $47.65 avg | 3,777 | $180K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-12 | $367K | — | Filing → |
| ADPT | SELL | 2025-03-12 | $402K | — | Filing → |
| HLVX | SELL | 2025-02-12 | $49K | — | Filing → |